For instance, it has been shown that BTLA weakens antitumor T cell activation by signaling via HVEM [138, 140] and BTLA inhibition augmented the propagation and antitumor activity of melanoma-specific CD8+ T cells [141]. This evidence concerns the gene BTLA and melanoma.